Sendai Medical Center

Miyagi 983-8520

1 studies enrolling now · 2 studies all time

What they study most

Hemophilia A, Moderately to Severely Active Crohns Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors — Completed